Learning Hub
Explore resources to help you understand and manage psoriatic arthritis.
Search
162 results found with an empty search
- iPROLEPSIS 5th Plenary Meeting in Athens | iPROLEPSIS
< BACK iPROLEPSIS 5th Plenary Meeting in Athens Dec 5, 2024 Advancing the Development of Digital Solutions for Psoriatic Arthritis Care The iPROLEPSIS consortium gathered in Athens, Greece, on 2-3 December 2024, for the 5th Plenary Meeting. Hosted by Netcompany-Intrasoft and Wellics, this two-day event brought together consortium partners, the External Advisory Board (EAB), and the Project Officer (PO) to discuss key updates and map out the next steps in developing a personalised digital care ecosystem for people with Psoriatic Arthritis (PsA). The meeting focused on project updates, key achievements, and future plans for the Psoriatic Arthritis digital care ecosystem. Day 1 covered progress in the project, co-creation activities, and updates from various work packages. The team also demonstrated the iPROLEPSIS tools, including the miPROLEPSIS apps, HCP’s dashboard, and the Lifestyle Recommendation System. On Day 2, workshops were held on study designs, ecosystem development, and predictive models. Discussions also focused on data governance and dissemination strategies. 1/8 PREVIOUS NEXT
- iPROLEPSIS Presented at the 7th Panhellenic Multidisciplinary Congress of Autoimmune Diseases, Rheumatology & Clinical Immunology | iPROLEPSIS
< BACK iPROLEPSIS Presented at the 7th Panhellenic Multidisciplinary Congress of Autoimmune Diseases, Rheumatology & Clinical Immunology Apr 7, 2025 Engaging the clinical community with updates on iPROLEPSIS and ongoing research From 28–30 March 2025, the 7th Panhellenic Multidisciplinary Congress of Autoimmune Diseases, Rheumatology & Clinical Immunology took place in Portaria, Greece. Maria Mytilinaiou , representing the Aristotle University of Thessaloniki (AUTH) , presented an overview of the iPROLEPSIS and HIPPOCRATES projects and ongoing clinical studies. The congress brought together clinicians and researchers from across Greece, offering a valuable opportunity to share insights and strengthen collaboration. 1/3 PREVIOUS NEXT
- iPROLEPSIS at IEEE-EMBS BSN 2025 | iPROLEPSIS
< BACK iPROLEPSIS at IEEE-EMBS BSN 2025 Nov 6, 2025 Showcasing iPROLEPSIS at a leading international conference on body sensor research The IEEE-EMBS International Conference on Body Sensor Networks (IEEE-EMBS BSN 2025) took place in Los Angeles, USA, from 3–5 November 2025. The conference brings together researchers, clinicians, and industry representatives working on body sensor technologies and their applications in health and biomedical research. iPROLEPSIS was showcased at the event by project partner PLUX , which hosted a dedicated booth. The project was presented to an international audience, increasing its visibility within the body sensor and digital health research community. IEEE EMBS 2025 2.HEIC IEEE EMBS 2025 1.HEIC IEEE EMBS 2025 3.HEIC IEEE EMBS 2025 2.HEIC 1/3 PREVIOUS NEXT
- iPROLEPSIS at Faculdade de Motricidade Humana PhD Seminar | iPROLEPSIS
< BACK iPROLEPSIS at Faculdade de Motricidade Humana PhD Seminar Dec 4, 2025 Lecture on recent findings shared with PhD students On 20 November 2025 , iPROLEPSIS was presented at Faculdade de Motricidade Humana (FMH) during the PhD seminar “Métodos de Investigação Avançada em Motricidade Humana”. Sofia Balula Dias spoke to more than 20 PhD students , presenting key findings from the project’s most recent publications and ongoing research on psoriatic arthritis. The session was an opportunity to share current scientific work and answer questions from the students. Slide1.JPG Slide2.JPG Slide8.JPG Slide1.JPG 1/8 PREVIOUS NEXT
- iPROLEPSIS Newsletter No. 7 | iPROLEPSIS
< BACK iPROLEPSIS Newsletter No. 7 Jan 28, 2025 Latest News from iPROLEPSIS Welcome to the 7th edition of the iPROLEPSIS newsletter. In this edition, we share the latest updates and progress from our project, including new developments, recent publications, and reflections on key events. iPROLEPSIS project newsletter_Jan 2025_Issue No. 7 .pdf Download PDF • 5.60MB 1/1 PREVIOUS NEXT
- iPROLEPSIS 3rd Plenary Meeting | iPROLEPSIS
< BACK iPROLEPSIS 3rd Plenary Meeting Nov 30, 2023 iPROLEPSIS 3rd Plenary Meeting in Rotterdam: 12-13 December 2023 On 12-13 December 2023, iPROLEPSIS partners will meet in Rotterdam for the third plenary meeting. The agenda includes workshops on the PDPID study, digital biomarkers, technical ecosystem development, serious games co-creation, an External Advisory Board session, and more. Stay tuned for updates on our progress! iPROLEPSIS 3rd Plenary meeting (1).png iPROLEPSIS 3rd Plenary meeting (1).png 1/1 PREVIOUS NEXT
- Advancing Psoriatic Arthritis: Rheumatologist Ilja Tchetverikov's Insights on iPROLEPSIS | iPROLEPSIS
< BACK Advancing Psoriatic Arthritis: Rheumatologist Ilja Tchetverikov's Insights on iPROLEPSIS May 22, 2024 Exploring Innovative Approaches to Disease Management and Patient Care in Psoriatic Arthritis" Ilja Tchetverikov , a rheumatologist and project partner from the CICERO Foundation (the Netherlands), provides insights into the iPROLEPSIS project's endeavours. He emphasises the need for a deeper understanding of psoriatic arthritis , a chronic inflammatory condition impacting various body parts due to immune system disturbances. I. Tchetverikov highlights the project's focus on investigating disease progression factors and developing non-invasive measurement tools . “Everybody can measure anything, but then you have to know what you're measuring. The whole idea of the project is that we combine two strengths. One of them is providing and developing a technical solution on how to measure the disease activity. And from the other side, we are going to label the data coming in from the system, from the clinical point of view. So we will be able to say whether or not some people have a low or high level of disease activity. So it's one part of the investigation. The other part of the investigation is to see whether other factors, which are already known to influence the whole system of your human body, like stress factors and some, for instance, gut microbiome composition, can also change during the course of the disease and how they are influencing the course of the disease itself,” states Ilja Tchetverikov . Through a collaborative effort integrating clinical expertise and technical innovation, the project aims to assess disease activity levels and explore external factors accurately. https://www.youtube.com/watch?v=PcUHfHsWSVs iPROLEPSIS interview.png iPROLEPSIS interview.png 1/1 PREVIOUS NEXT
- iPROLEPSIS Games Pitch video from HiTech 2025 | iPROLEPSIS
< BACK iPROLEPSIS Games Pitch video from HiTech 2025 Jul 24, 2025 iPROLEPSIS Games presented during the HiSeedTech programme The iPROLEPSIS Games were presented at HiTech 2025 , a program by HiSeedTech. The pitch introduced the use of serious games to support treatment for Psoriatic Arthritis (PsA) , focusing on symptoms like mobility, pain, breathing, and emotional well-being. Watch the presentation here: https://www.youtube.com/watch?v=Jl4xYRL6wqI HiTech 2025.png HiTech 2025.png 1/1 PREVIOUS NEXT
- Clinical Experts | iPROLEPSIS
Clinical experts team Gail Heritage University of Oxford Position Senior Research Manager What is your role in iPROLEPSIS? UK PDPID coordinating center Manager What are your main activities in the project? UK Study manager What is your motivation? Contribution to clinical research to enhance patient experiences and disease outcomes. Francesca Levi-Schaffer The Hebrew University of Jerusalem, Israel Position Professor What is your role in iPROLEPSIS? Researcher What are your main activities in the project? To try to understand the passage from psoriasis to psoriatic arthritis by evaluating in skin biopsies vascularization, mast cell presence and to correlate this with involved joint vascularization What is your motivation? I would like to discover the connections between skin and joints and find a drug/s that can inhabit this progression Laura Coates Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Position NIHR Research Professor What is your role in iPROLEPSIS? Lead for WP5 (clinical studies) What are your main activities in the project? I oversee all of the clinical studies within the consortium. What is your motivation? I am a rheumatologist who has worked in research in psoriatic arthritis for around 20 years. My interest is in improving outcomes for people living with psoriatic arthritis and I believe that work in this project can help us to predict, monitor and understand the disease better in day to day clinics. Coordination Clinical Experts Data Science Software Development Ethics, Legal and Exploitation Dissemination and Communication
- iPROLEPSIS presented at TeraMed Conference 2026 in Angola | iPROLEPSIS
< BACK iPROLEPSIS presented at TeraMed Conference 2026 in Angola Apr 22, 2026 The project and the iPROLEPSIS Games were presented, highlighting their relevance for digital health innovation Filipa Magalhães from Faculdade de Motricidade Humana/ Instituto Superior Técnico presented the iPROLEPSIS project and the iPROLEPSIS Games at the TeraMed Conference 2026 , held on 16 April 2026 in Angola. The conference brought together various stakeholders to discuss the challenges and opportunities of implementing digital solutions in healthcare, particularly in the Angolan context. During the event, Filipa Magalhães presented the iPROLEPSIS project and the iPROLEPSIS Games , highlighting their objectives and innovative approach. Given the limited availability of psoriatic arthritis-related data in Angola and other African countries, she emphasised the project’s potential to support the development of digital health solutions through a gamified approach , especially in regions with one of the youngest populations in the world. The co-creation methodology used in the development of the iPROLEPSIS Games was also showcased as a strong example for developers, reinforcing the importance of involving users from the early stages in order to better address real needs and increase patient engagement. As part of the event, Filipa Magalhães also gave an interview to RTP Africa, where she discussed the complexity of psoriatic arthritis and explained how this led to the creation of different game categories addressing various symptoms within the iPROLEPSIS Games. The interview also highlighted the potential impact of digital health interventions in this area. Screenshot 2026-04-21 at 12.37.49.png WhatsApp Image 2026-04-17 at 20.32.00.jpeg Screenshot 2026-04-21 at 12.37.49.png 1/2 PREVIOUS NEXT
- iPROLEPSIS Newsletter No. 10 | iPROLEPSIS
< BACK iPROLEPSIS Newsletter No. 10 Nov 6, 2025 Latest News from iPROLEPSIS Welcome to the tenth edition of the iPROLEPSIS newsletter, where we share the latest updates and progress from the project. iPROLEPSIS project newsletter Issue No. 10_Nov 2025 .pdf Download PDF • 9.31MB Newsletter 10 cover for article.png Newsletter 10 cover for article.png 1/1 PREVIOUS NEXT
- iPROLEPSIS presented at MEDICA 2023 | iPROLEPSIS
< BACK iPROLEPSIS presented at MEDICA 2023 Nov 14, 2023 iPROLEPSIS project presented at the world’s largest event for the medical sector Project partners Amalia Ntemou ( Netcompany-Intrasoft ) and Georgios Apostolidis ( Aristotle University of Thessaloniki (AUTH) ) presented the iPROLEPSIS project at the MEDICA - Leading International Trade Fair in Germany. MEDICA is the world’s largest event for the medical sector. It attracts several thousand exhibitors from more than 50 countries in the halls. Furthermore, each year, leading individuals from business, research, and politics grace this top-class event with their presence. MEDICA 2023 took place on 13-16 November in Düsseldorf, Germany. IMG_20231115_135346.jpg IMG_20231115_135346.jpg 1/1 PREVIOUS NEXT
